Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Versant Ventures was founded in 1999 and manages $5.3B in AUM, making it one of the most successful life sciences VCs globally. The most recent raise totaled $950M across three vehicles — $560M for company formation, $140M for co-investment, and $250M for growth.
The portfolio spans 190 companies with 95+ acquisitions and IPOs. What distinguishes Versant is its "Discovery Engines" — in-house scie...
Notable Investments
A
Audentes TherapeuticsC
Crinetics PharmaceuticalsA
AtrecaSimilar Funds
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
+C
+ND Capital
Woodside, CA, United States
Pure DeepTechBiotechAdvanced MaterialsSemiconductorsSeedSeries A
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedtechSeedSeries A
AP
AdBio Partners
Paris, France
Pure DeepTechBiotechSynthetic BiologyMedtechSeedSeries A
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed